IRIS

To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope(®), a somatropin biosimilar to Genotropin(®), in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults study.

Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study / Ferone, Diego; Profka, E; Gasco, V; Ambrosio, M. R; Colao, Annamaria; DI SOMMA, Carolina; Puxeddu, E; Arnaldi, G; Pagano, C; Zecchi, E; Pietropoli, A; Beck Peccoz, P.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - 40:6(2017), pp. 669-678. [10.1007/s40618-016-0604-8]

Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study

FERONE, DIEGO;COLAO, ANNAMARIA;DI SOMMA, CAROLINA;
2017

Abstract

To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope(®), a somatropin biosimilar to Genotropin(®), in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults study.
2017
Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study / Ferone, Diego; Profka, E; Gasco, V; Ambrosio, M. R; Colao, Annamaria; DI SOMMA, Carolina; Puxeddu, E; Arnaldi, G; Pagano, C; Zecchi, E; Pietropoli, A; Beck Peccoz, P.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - 40:6(2017), pp. 669-678. [10.1007/s40618-016-0604-8]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/680820
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact